What percent of AIM is sold short?

54.7% of AIM ImmunoTech (AIM) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is AIM a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for AIM ImmunoTech (AIM).

AIM Short Volume Hit 54.7%

$0.18

-0.01 (-4.10%)

Weekly Expected Move ±7.6%

$0 $0 $0 $0 $0

AMEX · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $7.1M mcap · 28M float · 80.21% daily turnover · Short 53% of daily vol

Short Volume Summary

2026-10-01

50.0%

Short Ratio

of total volume

51.5%

20-Day Avg

51.2%

50-Day Avg

▲ Rising

5-Day Trend

0.1M

Short Volume

0.3M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	142,569	283,397	50.3%
NYSE	2,702	6,920	39.0%

AIM Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet